LA
BMY icon

LBP AM’s Bristol-Myers Squibb BMY Stock Holding History

LBP AM’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.3M Sell
170,325
-147,721
-46% -$8.61M 0.14% 148
2025
Q4 		$17.2M Sell
318,046
-56,713
-15% -$2.73M 0.2% 102
2025
Q3 		$16.9M Sell
374,759
-15,780
-4% -$737K 0.21% 96
2025
Q2 		$18.1M Sell
390,539
-33,180
-8% -$1.63M 0.25% 80
2025
Q1 		$25.8M Sell
423,719
-15,400
-4% -$898K 0.4% 56
2024
Q4 		$24.8M Buy
439,119
+90,586
+26% +$5.06M 0.34% 64
2024
Q3 		$18M Buy
348,533
+278,644
+399% +$13.1M 0.27% 77
2024
Q2 		$2.9M Buy
69,889
+16,383
+31% +$733K 0.12% 136
2024
Q1 		$2.9M Sell
53,506
-446,239
-89% -$22.7M 0.12% 146
2023
Q4 		$25.6M Sell
499,745
-73,482
-13% -$3.86M 0.57% 47
2023
Q3 		$33.3M Buy
573,227
+23,838
+4% +$1.46M 0.74% 32
2023
Q2 		$35.1M Buy
549,389
+450,564
+456% +$30.2M 0.83% 29
2023
Q1 		$6.85M Sell
98,825
-4,550
-4% -$321K 0.17% 120
2022
Q4 		$7.44M Buy
+103,375
New +$7.79M 0.21% 101

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LBP AM's BMY Position: Q1 2026 in Review

LBP AM reduced its Bristol-Myers Squibb (BMY) stake by 46% in Q1 2026, selling an estimated $8.61M and leaving 170,325 shares worth $10.3M. The position accounts for 0.14% of the portfolio, ranked #148.

LBP AM first reported a position in BMY in Q4 2022 and has held it in 14 quarters since. The position peaked at $35.1M in Q2 2023. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • LBP AM held 170,325 shares of Bristol-Myers Squibb worth $10.3M as of Q1 2026.
  • LBP AM sold 147,721 Bristol-Myers Squibb shares in Q1 2026, an estimated $8.61M.
  • Bristol-Myers Squibb made up 0.14% of LBP AM's portfolio in Q1 2026, its #148 holding.
  • LBP AM first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 14 quarters since.
  • LBP AM's Bristol-Myers Squibb position peaked at $35.1M in Q2 2023.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on LBP AM's 13F filing for Q1 2026, filed 27 Apr 2026.